216
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Monte Carlo single-cell dosimetry of I-131, I-125 and I-123 for targeted radioimmunotherapy of B-cell lymphoma

, &
Pages 908-915 | Received 05 Sep 2011, Accepted 07 Feb 2012, Published online: 13 Mar 2012

References

  • Bardiès M, Chatal JF. 1994. Absorbed dose for internal radiotherapy from 22 beta-emitting radionuclides: Beta dosimetry of small spheres. Physics in Medicine and Biology 39:961–981.
  • Bardiès M, Lamé J, Myers MJ, Simoen JP. 1990. A simplified approach to beta dosimetry for small spheres labelled on the surface. Physics in Medicine and Biology 35:1039–1050.
  • Behr TM, Béhé M, Löhr M, Sgouros G, Angerstein C, Wehrmann E, Nebendahl K, Becker W. 2000. Therapeutic advantages of Auger electron- over β-emitting radiometals or radioiodine when conjugated to internalizing antibodies. European Journal of Nuclear Medicine 27:753–765.
  • Berger MJ. 1973. Improved point kernels for electron and beta-ray dosimetry. NBSIR 73–107. Gaithersburg MD: National Bureau of Standards.
  • Berger MJ. 1963. Monte Carlo calculation of the penetration and diffusion of fast charged particles. In: Alder B, Fernbach S, Rotenberg M, editors. Methods in computational physics. New York: Academic Press. pp 135–215.
  • Bishayee A, Rao DV, Bouchet LG, Bolch WE, Howell RW. 2000a. Protection by DMSO against cell death caused by intracellularly localized Iodine-125, Iodine-131, and Polonium-210. Radiation Research 153:416–427.
  • Bishayee A, Rao DV, Howell RW. 2000b. Radiation protection by cysteamine against the lethal effects of intracellularly localized Auger electron, alpha-, and beta-particle emitting radionuclides. Acta Oncologica 39:713–720.
  • Bousis C, Emfietzoglou D, Hadjidoukas P, Nikjoo H. 2008a. A Monte Carlo study of absorbed dose distributions in water in the vapour and liquid phases by intermediate energy electrons based on different condensed-history transport schemes. Physics in Medicine and Biology 53:3739–3761.
  • Bousis C, Emfietzoglou D, Hadjidoukas P, Nikjoo H, Pathak A. 2008b. Electron ionization cross-section calculations for liquid water at high impact energies. Nuclear Instruments and Methods in Physics Research B: Beam Interactions with Materials & Atoms 266:1185–1192.
  • Bousis C, Emfietzoglou D, Nikjoo H, Hadjidoukas P, Pathak A. 2009a. The effects of energy-loss straggling and elastic scattering models on Monte Carlo calculations of dose distribution functions for 10 keV to 1 MeV incident electrons in water. Nuclear Instruments and Methods in Physics Research B: Beam Interactions with Materials & Atoms 267:1725–1732.
  • Bousis C, Emfietzoglou D, Hadjidoukas P, Nikjoo H. 2009b. A Monte Carlo study of cellular S-factors for 1 keV to 1 MeV electrons. Physics in Medicine and Biology 54:5023–5038.
  • Bousis C, Emfietzoglou D, Hadjidoukas P, Nikjoo H. 2010. Monte Carlo single-cell dosimetry of Auger-electron emitting radionuclides. Physics in Medicine and Biology 55:2555–2572.
  • Bousis C. 2011. Dosimetry on sub-cellular level for intracellular incorporated Auger-electron-emitting radionuclides: A comparison of Monte Carlo simulations and analytic calculations. Radiation Protection Dosimetry 143:33–41.
  • Brans B, Lindén O, Giammarile F, Tennvall J, Punt C. 2006. Clinical application of newer radionuclide therapies. European Journal of Cancer 42:994–1003.
  • Brenner DJ, Zaider M. 1983. A computationally convenient parametrization of experimental angular distributions of low energy electrons elastically scattered off water vapour. Physics in Medicine and Biology 29:443–447.
  • Buchegger F, Perillo-Adamer F, Dupertuis YM, Bischof Delaloye A. 2006. Auger radiation targeted into DNA: A therapy perspective. European Journal of Nuclear Medicine and Molecular Imaging 33:1352–1363.
  • Campos L, Da Silva F. 2008. Dosimetry in thyroid follicles due to low-energy electrons of iodine using the Monte Carlo method. Radio-logia Brasileira 41:403–407.
  • Champion C, Zanotti-Fregonara P, Hindié E. 2008. CELLDOSE: A Monte Carlo code to assess electron dose distribution-S values for 131I in spheres of various sizes. Journal of Nuclear Medicine 49:151–157.
  • Chan PC, Lisco E, Lisco H, Adelstein SJ. 1976. The radiotoxicity of iodine-125 in mammalian cells. A comparative study on cell survival and cytogenic responses to 125IUdR, 131IUdR and 3HTdR. Radiation Research 67:332–343.
  • Cross WG, Ing H, Freedman NO. 1983. A short atlas of beta-ray spectra. Physics in Medicine and Biology 28:1251–1260.
  • DeNardo SJ, Williams LE, Leigh BR, Wahl RL. 2002. Choosing an optimal radioimmunotherapy dose for clinical response. Cancer 94:1275–1286.
  • Emfietzoglou D, Papamichael G, Kostarelos K, Moschovitch M. 2000. A Monte Carlo track structure code for electrons (∼10 eV–10 keV) and protons (∼ 0.3–10 MeV) in water: Partitioning of energy and collision events. Physics in Medicine and Biology 45:3171–3194.
  • Emfietzoglou D, Bousis C, Hindorf C, Fotopoulos A, Pathak A, Kostarelos K. 2007. A Monte Carlo study of energy deposition at the sub-cellular level for application to targeted radionuclide therapy with low-energy electron emitters. Nuclear Instruments and Methods in Physics Research B: Beam Interactions with Materials & Atoms 256:547–553.
  • Emfietzoglou D, Kostarelos K, Hadjidoukas P, Bousis C, Fotopoulos A, Pathak A, Nikjoo H. 2008. Subcellular S-factors for low-energy electrons: A comparison of Monte Carlo simulations and continuous-slowing-down calculations. International Journal of Radiation Biology 84:1034–1044.
  • Feinendegen LE. 1975. Biological damage from the Auger effect, possible benefits. Radiation Environmental Biophysics 12:85–99.
  • Goddu SM, Rao DV, Howell RW. 1994. Multicellular dosimetry for micrometastases: Dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. Journal of Nuclear Medicine 35:521–530.
  • Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao DV. 1997. MIRD Cellular S values. Reston VA: Society of Nuclear Medicine.
  • Govindan SV, Mattes MJ, Stein R, McBride BJ, Karacay H, Goldenberg DM, Hansen HJ, Griffiths GL. 1999. Labeling of monoclonal antibodies with diethylenetriaminepentaacetic acid-appended radioiodinated peptides containing D-amino acids. Bioconjugate Chemistry 10:231–240.
  • Govindan SV, Goldenberg DM, Elsamra SE, Griffiths GL, Ong GL, Brechbiel MW, Burton J, Sgouros G, Mattes MJ. 2000. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: Comparison of Auger electron emitters with β-particle emitters. Journal of Nuclear Medicine 41:2089–2097.
  • Griffiths GL, Govindan SV, Sgouros G, Ong GL, Goldenberg DM, Mattes MJ. 1999. Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies. International Journal of Cancer 81:985–992.
  • Hansen HJ, Ong GL, Diril H, Valdez A, Roche PA, Griffiths GL, Goldenberg DM, Mattes MJ. 1996. Internalization and catabolism of radiolabeled antibodies to the MHC class-II invariant chain by B-cell lymphomas. Biochemistry Journal 320:293–300.
  • Hindié E, Champion C, Zanotti-Fregonara P, Rubello D, Colas-Linhart N, Ravasi L, Moretti JL. 2009. Calculation of electron dose to target cells in a complex environment by Monte Carlo code “CELLDOSE”. European Journal of Nuclear Medicine and Molecular Imaging 36:130–136.
  • Hindorf C, Emfietzoglou D, Lindén O, Bousis C, Fotopoulos A, Kostarelos K, Flux GD. 2007. Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spread. Cancer Biotherapy and Radiopharmaceuticals 22: 357–366.
  • Howell RW. 2008. Auger processes in the 21st century. International Journal of Radiation Biology 84:959–975.
  • Howell RW, Rao DV, Sastry KSR. 1989. Macroscopic dosimetry for radioimmunotherapy: Nonuniform activity distributions in solid tumors. Medical Physics 16:66–74.
  • Howell RW. 1992. Radiation spectra for Auger-electron emitting radionuclides: Report No.2 of AAPM Nuclear Medicine Task Group No. 6a). Medical Physics 19:1371–1383.
  • Howell RW, Goddu SM, Bishayee A, Rao DV. 1998. Radioprotection against lethal damage caused by chronic irradiation with radionuclides in vitro. Radiation Research 150:391–399.
  • Humm JL, Roeske JC, Fisher DR, Chen GTY, Howell RW, Rao DV. 1993. Microdosimetry concepts in radioimmunotherapy. Medical Physics 20:535–541.
  • Humm JL, Howell RW, Rao DV. 1994. Dosimetry of Auger-electron-emitting radionuclides: Report no.3 of AAPM Nuclear Medicine Task Group No. 6. Medical Physics 21:1901–1915.
  • Inokuti M. 1971. Inelastic collisions of fast charged particles with atoms and molecules – The Bethe theory revisited. Reviews of Modern Physics 43:297–347.
  • Kassis AI, Adelstein SJ. 2004. Radiobiologic principles in radionuclide therapy. Journal of Nuclear Medicine 46:4S–12S.
  • Kassis AI. 2008. Therapeutic radionuclides: Biophysical and radiobiologic principles. Seminars in Nuclear Medicine 38:358–366.
  • Kassis AI. 2004. The amazing world of Auger electrons. International Journal of Radiation Biology 80:789–803.
  • Kim YK. 1972. Angular distribution of secondary electrons in the dipole approximation. Physics Review A 6:666–670.
  • Kim YK, Santos JP, Parente F. 2000. Extension of the binary-encounter-dipole model to relativistic incident electrons. Physics Review A 62:1–14.
  • Li WB, Friedland W, Pomplun E, Jacob P, Paretzke HG, Lassmann M, Reiners C. 2001. Track structures and dose distributions from decays of 131I and 125I in and around water spheres simulating micrometastases of differentiated thyroid cancer. Radiation Research 156:419–429.
  • Loevinger R, Budinger TF, Watson EE. 1991. MIRD primer for absorbed dose calculations, revised. New York: Society of Nuclear Medicine.
  • Michel RB, Brechbiel MW, Mattes MJ. 2003. A comparison of 4 radionuclides conjugated to antibodies for single-cell kill. Journal of Nuclear Medicine 44:632–640.
  • Narra VR, Howell RW, Harapanhalli RS, Sastry KSR, Rao DV. 1992. Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: Implications for radiopharmaceutical design. Journal of Nuclear Medicine 33:2196–2201.
  • Neti PV, Howell RW. 2003. When may a nonuniform distribution of I131 be considered uniform? An experimental basis for multicellular dosimetry. Journal of Nuclear Medicine 44:2019–2026.
  • Neti PV, Howell RW. 2004. Isolating effects of microscopic nonuniform distributions of I131 on labeled and unlabeled cells. Journal of Nuclear Medicine 45:1050–1058.
  • Nikjoo H, Uehara S, Emfietzoglou D, Cucinotta FA. 2006. Track-structure codes in radiation research. Radiation Measurements 41:1052–1074.
  • Pomplun E, Booz J, Charlton DE. 1987. A Monte Carlo simulation of Auger cascades. Radiation Research 111:533–552.
  • Press OW, Farr AG, Borroz KI, Anderson SK, Martin PJ. 1989. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Research 49:4906–4912.
  • Salvat F, Fernández-Varea JM, Sempau J. 2003. PENELOPE: A code system for Monte Carlo simulation of electron and photon transport. OECD/NEA Workshop Proceedings, Issy-les-Moulineaux, France. Available from http://www.nea.fr/html/dbprog/peneloperef.html
  • Sastry KSR, Rao DV. 1984. Dosimetry of low energy electrons. In: Rao DV, Chandra R, Graham M, editors. Physics of nuclear medicine: Recent advances. New York: American Institute of Physics. pp 169–208.
  • Sastry KSR. 1992. Biological effects of the Auger emitter 125I: A review. Report No. 1 of AAPM Nuclear Medicine Task Group No. Medical Physics. 6. 19:1361–1370.
  • Sgouros G. Knox SJ, Joiner MC, Morgan WF, Kassis AI. 2007. MIRD continuing education: Bystander and low-dose-rate effects: Are these relevant to radionuclide therapy? Journal of Nuclear Medicine 48:1683–1691.
  • Siegel JA, Stabin MG, Sparks RB. 2003. Total-body and red marrow dose estimates. Journal of Nuclear Medicine 44:320–321.
  • Song H, Du Y, Sgouros G, Prideaux A, Frey E, Wahl RL. 2007. Therapeutic potential of 90Y- and 131I-labeled anti-CD20 monoclonal antibody in treating non-Hodgkin's lymphoma with pulmonary involvement: A Monte Carlo-based dosimetric analysis. Journal of Nuclear Medicine 48:150–157.
  • Spaic R, Ilic R, Petrovic B, Toskovic F. 2007. Referent 3D solid tumour model and absorbed dose calculations at cellular level in radionuclide therapy. World Journal of Nuclear Medicine 6:45–51.
  • Stabin M. 2003. Developments in the internal dosimetry of radiopharmaceuticals. Radiation Protection and Dosimetry 105:575–580.
  • Stabin M, Konijnenberg MW. 2000. Re-evaluation of absorbed fractions for photons and electrons in spheres of various sizes. Journal of Nuclear Medicine 41:149–160.
  • Stein R, Govindan SV, Mattes MJ, Chen S, Reed L, Newsome G, McBride BJ, Griffiths GL, Hansen HJ, Goldenberg DM. 2003. Improved iodine radiolabels for monoclonal antibody therapy. Cancer Research 63:111–118.
  • Strigari L, Menghi E, D'Andrea M, Benassi M. 2006. Monte Carlo dose voxel kernel calculations of beta-emitting and Auger-emitting radionuclides for internal dosimetry: A comparison between EGSnrcMP and EGS4. Medical Physics 33:3383–3389.
  • Torres-García E, Garnica-Garza HM, Ferro-Flores G. 2006. Monte Carlo microdosimetry of 188Re and 131I-labelled anti-CD20. Physics in Medicine and Biology 51:N349–356.
  • Unak P, Cetinkaya B. 2005. Absorbed dose estimates at the cellular level for 131I. Applied Radiation and Isotopes 62:861–869.
  • Weber DA, Eckerman KF, Dillman LT, Ryman JC. 1989. MIRD: Radionulide data and decay schemes. New York: Society of Nuclear Medicine.
  • Wheldon TE, O'Donoghue JA. 1990. The radiobiology of targeted radiotherapy. International Journal of Radiation Biology 58:1–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.